Immunity to SARS-CoV-2: Exploring and understanding the COVID-19 disease

For the doctoral thesis Seminar # 902.218

Program (pdf)

For the doctoral thesis Seminar # 902.218

Coordination:

Dr. Anna Repic, Prof. Dr. Johannes Huppa, Dr. Philipp
Schatzlmaier, Prof. Dr. Hannes Stockinger

Topic for the Winter semester 2020/2021:

Immunity to SARS-CoV-2: Exploring and
understanding the COVID-19 disease

Venue:

Virtual meeting via Webex
Time: January 25-26, 2020

Day 1: Monday January 25:

Meeting: Link
Meeting number (access code): 121 287 9576,
Meeting password: PredHH5zJ86 (77334459 from video systems)

13.00 – 13.15 Coordinators (ANNA REPIC)

Welcome, Introduction to and Overview of the Topic

13.15 – 13.35 Martin Temes

Pathogenic and seasonal coronaviruses affecting
humans: similarities and differences

13.35 – 13.50 Discussion

13.50 – 14.10 René Platzer

SARS-CoV-2 emergence and successful worldwide
spread: SARS-CoV-2 epidemiology and molecular
mechanisms that allowed successful global
transmission

14.10 – 14.25 Discussion

14.25 – 14.45 Timo Peters

Pathogenesis of COVID-19 I: Early infection (on the
cellular and tissue level), symptoms, pulmonary and
extrapulmonary manifestations

14.45 – 15.00 Discussion

15.00 – 15.15 Break

15.15 – 15.35 Konstantin Hölzl

Pathogenensis of COVID-19 II. Neurological and
olfactory manifestations (and underlying molecular
mechanisms), COVID-19 delirium and role of neuropilin-1

15.35 – 15.50 Discussion

15.50 – 16.10 Vlado LEksa (perhaps)

Effect of SARS-CoV-2 infection on systemic proteolytic
systems: renin–angiotensin–aldosterone system and
bradykinin, coagulation/fibrinolytic systems

16.10 – 16.25 Discussion

16.25 – 16.45 Philipp Schatzlmaier

Blood biomarkers as predictors of severe COVID-19
16.45 – 17.00 Discussion

Day 2: Tuesday January 26:

Meeting: Link
Meeting number (access code): 121 925 8748,
Meeting password: xpC7nt3HV3s (97276834 from video systems)

13.00 – 13.20 Anna Repic

SARS-CoV-2 mechanisms of host defence suppression

13.20 – 13.35 Discussion

13.35 – 13.55 Venu Gudipati

Role of T cells in recognizing and fighting SARS-CoV-2 infection

13.55 – 14.10 Discussion

14.10 – 14.30 Romana Klasinc

High age and underlying health conditions (obesity, hypertension, mutations in immune genes or
autoantibodies against type I IFNs) as risk factors for severe COVID-19

14.30 – 14.45  Discussion

14.45 – 15.05 Angelika Plach

SARS-CoV-2 test, trace, isolate (and mask) strategy as
means to limit the virus spread

15.05 – 15.35 Discussion

15.35 – 15.50 Break

15.50– 16.10 Laura Gebetsberger

COVID-19 treatments: differences in effectivity in vitro and in vivo

16.10 – 16.25 Discussion

16.35 – 16.55 Janett Göhring

SARS-CoV-2 vaccine development: what it takes to make
a safe and effective vaccine and the current status of SARS-CoV-2 vaccines

16.55 – 17.10 Discussion

17.10 – 17.30 Final discussion

(to a bonus topic: COVID-19 misinformation and how to
tackle it with scientific knowledge)